Ptc Therapeutics, Inc. · NASDAQ:PTCT

Almstead Neil Gregory sold 8,130 Ptc Therapeutics, Inc. shares (Form 4)

Traded Jun 26, 2026 · Filed Jun 30, 2026

On Jun 26, 2026, Almstead Neil Gregory (CHIEF TECHNICAL OPS OFFICER) sold 8,130 Ptc Therapeutics, Inc. shares at an average US$85.26 for US$693K under a trading plan, leaving 60,137 shares. Filed Jun 30, 2026 (Form 4).

Sold
8,130 shares
Price
US$85.26 average (US$85.23 to US$85.26)
Value
US$693K
Holding after
60,137 shares
Trading plan
Yes (Made under a plan set in advance)
Role
CHIEF TECHNICAL OPS OFFICER

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 26, 2026Common StockOption exercise412US$38.1060,549Direct
Jun 26, 2026Common StockSale412US$85.2360,137Direct
Jun 26, 2026Common StockOption exercise7,718US$38.1067,855Direct
Jun 26, 2026Common StockSale7,718US$85.2660,137Direct

Source

View original at SEC

Related